Delayed denosumab injections raise vertebral fracture risks
Endocrinology and Metabolism
Long-term follow up after denosumab treatment for osteoporosis – rebound associated with hypercalcemia, parathyroid hyperplasia, severe bone mineral density loss, and multiple fractures: a case report | Journal of Medical Case Reports
Discontinuation of Denosumab therapy for osteoporosis: A systematic review and position statement by ECTS - ScienceDirect
Long-term follow up after denosumab treatment for osteoporosis – rebound associated with hypercalcemia, parathyroid hyperplasia, severe bone mineral density loss, and multiple fractures: a case report | Journal of Medical Case Reports
PDF) Long-term follow up after denosumab treatment for osteoporosis – rebound associated with hypercalcemia, parathyroid hyperplasia, severe bone mineral density loss, and multiple fractures: a case report
Rebound-associated vertebral fractures after denosumab discontinuation in a lung cancer patient with bone metastases - ScienceDirect
Vertebral fractures after denosumab cessation | Cleveland Clinic Journal of Medicine
THERAPY OF ENDOCRINE DISEASE: Denosumab vs bisphosphonates for the treatment of postmenopausal osteoporosis in: European Journal of Endocrinology Volume 179 Issue 1 (2018)
Denosumab in the Treatment of Osteoporosis: 10 Years Later: A Narrative Review | SpringerLink
Prolia for Bone Fractures — I'm Still Not Impressed - Better Bones, Better Body
DENOSUMAB
Denosumab: Mechanisms and Therapeutic Effects in the Treatment of Osteoporosis | SpringerLink
Rebound-associated vertebral fractures after denosumab discontinuation in a lung cancer patient with bone metastases - ScienceDirect
To Prevent Fractures, Get the Order of Osteoporosis Drugs Right, Study Says | Everyday Health
Rapid Bone Loss and Multiple Vertebral Fractures After Denosumab Cessation – Consult QD
Can Rare Rebound Fractures After Denosumab Therapy Be Avoided?
Frontiers | A Multi-Institutional Randomized Controlled Trial to Investigate Whether Zoledronate Prevents Bone Loss After Discontinuation of Denosumab: The Study Protocol of Denosumab Sequential Therapy (DST) Trial
Romosozumab was not effective in preventing multiple spontaneous clinical vertebral fractures after denosumab discontinuation: A case report - ScienceDirect
Prolia for Bone Fractures — I'm Still Not Impressed - Better Bones, Better Body
Romosozumab was not effective in preventing multiple spontaneous clinical vertebral fractures after denosumab discontinuation: A case report - ScienceDirect
Frontiers | Elevated Bone Hardness Under Denosumab Treatment, With Persisting Lower Osteocyte Viability During Discontinuation
